相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)
Mediators of anaphylactic reactions: Tryptase and histamine stability in whole blood
Julien Serrier et al.
ALLERGY (2021)
Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease
Saptarshi Roy et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Divergent PGD2 and leukotriene C4 metabolite excretion following aspirin therapy: Ten patients with systemic mastocytosis
Joseph H. Butterfield et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2021)
MRGPRX2 and Adverse Drug Reactions
Benjamin D. McNeil
FRONTIERS IN IMMUNOLOGY (2021)
Exercise-induced anaphylaxis unrelated to food ingestion and with hyperleukotrieneuria during challenge testing
Chikako Motomura et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2021)
Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production
Araceli Tobio et al.
HAEMATOLOGICA (2020)
Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation
Joseph H. Butterfield
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)
KIT D816V and the cytokine storm in mastocytosis: production and role of interleukin-6
Peter Valent
HAEMATOLOGICA (2020)
The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome
Joseph Butterfield et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?
Theoharis C. Theoharides et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management
Mariana Castells et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: The results of a double-blind, placebo-controlled challenge study
M. A. W. Hermans et al.
ALLERGY (2018)
A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis
Melody C. Carter et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression
A. Mayado et al.
LEUKEMIA (2016)
Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis
Alan J. Lueke et al.
CLINICAL BIOCHEMISTRY (2016)
Prostaglandin D2 metabolites as a biomarker of in vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis
Catherine Cho et al.
IMMUNITY INFLAMMATION AND DISEASE (2016)
Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders
R. Divekar et al.
ALLERGY (2015)
Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease
Milda Vysniauskaite et al.
PLOS ONE (2015)
Stress triggers coronary mast cells leading to cardiac events
Michail Alevizos et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2014)
Mast Cell Activation Syndrome: Improved Identification by Combined Determinations of Serum Tryptase and 24-Hour Urine 11β-Prostaglandin2α
Anupama Ravi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Evaluation of the inhibitory effect of various drugs / active ingredients on the activity of human diamine oxidase in vitro
Roland Leitner et al.
Clinical and Translational Allergy (2014)
Histamine production by human neutrophils
Lorena Alcaniz et al.
FASEB JOURNAL (2013)
Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis
A. Pardanani et al.
LEUKEMIA (2013)
Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions
J. J. van Doormaal et al.
ALLERGY (2012)
Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes
Tanya M. Laidlaw et al.
BLOOD (2012)
IL-6/IL-6 receptor system and its role in physiological and pathological conditions
Masahiko Mihara et al.
CLINICAL SCIENCE (2012)
Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
Peter Valent et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
The basics of histamine biology
Phil Lieberman
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2011)
Histamine: New Thoughts About a Familiar Mediator
B. L. Jones et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Bleeding diathesis in patients with mast cell activation disease
Holger Seidel et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma
H. Mita et al.
ALLERGY (2010)
Transcellular biosynthesis of eicosanoids
Angelo Sala et al.
PHARMACOLOGICAL REPORTS (2010)
Increased leukotriene E4 excretion in systemic mastocytosis
Joseph H. Butterfield
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)
Transcellular biosynthesis of eicosanoids
Angelo Sala et al.
PHARMACOLOGICAL REPORTS (2010)
“Heparinization” and hyperfibrinogenolysis by wasp sting
Cristina Lombardini et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2009)
Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis
E. Ono et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Survey of aspirin administration in systemic mastocytosis
Joseph H. Butterfield
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2009)
Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis
Christoph Sucker et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2008)
Ocular mast cells and mediators
Anne-Marie A. Irani
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D(2) Production
Joseph H. Butterfield et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)
Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans
Wen-Liang Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Urinary leukotriene E4
Nathan Rabinovitch
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Histamine and histamine intolerance
Laura Maintz et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis
Leah M. Lamale et al.
UROLOGY (2006)
Structural basis for inhibition of histamine N-methyltransferase by diverse drugs
JR Horton et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Mast cells and eosinophils: A novel link between inflammation and angiogenesis in allergic diseases
I Puxeddu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis
K Brockow et al.
CLINICAL IMMUNOLOGY (2005)
Evidence of mast cell activation and leukotriene release after mannitol inhalation
JD Brannan et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
IL-6 enhances IgE-dependent histamine release from human peripheral blood-derived cultured mast cells
T Kikuchi et al.
CYTOKINE (2002)
Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients
TC Theoharides et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: Correlation with dermal mast-cell numbers and mast-cell tryptase
K Brockow et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Are adverse effects of sildenafil also caused by inhibition of diamine oxidase?
F Wantke et al.
UROLOGIA INTERNATIONALIS (2001)
Prostaglandin D2 as a mediator of allergic asthma
T Matsuoka et al.
SCIENCE (2000)
Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics
AJ Macfarlane et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)